Nuvectis Pharma up after FDA grants orphan drug tag to cancer treatment

Nuvectis Pharma

17/08/2023 15:36

** Nuvectis Pharma's shares  NVCT.O  rise 1.8% to $14.5
    ** Drug developer said FDA granted orphan drug designation
for its treatment of bile duct cancer 
    ** Orphan drug tag provides certain financial incentives to
support the clinical development of drugs intended to treat rare
diseases or conditions
    ** Including session gains, stock up ~94% YTD 

 (Reporting by Khushi Mandowara in Bengaluru)
 ((Khushi.Mandowara@thomsonreuters.com;))